Prenetics Enters Bitcoin Arena with $20M Bet, Signaling a New Era for Healthcare and Crypto

42

Prenetics Global, a Nasdaq-listed health sciences company based in Hong Kong and the U.S., has invested $20 million in Bitcoin, officially becoming the first healthcare firm to launch a Bitcoin treasury strategy. The acquisition includes 187.42 BTC, purchased at an average price of $106,712 per coin through a Kraken custody account, as confirmed in a company statement shared with PRIME.

The bold move places Prenetics among the growing list of corporations — inspired by MicroStrategy’s $60B holdings and Metaplanet’s aggressive crypto strategy — choosing to hold Bitcoin as a core balance sheet asset.

From Biotech to Bitcoin: A Strategic Financial Shift

Earlier on the same day, Prenetics finalized the divestment of ACT Genomics, a decision that unlocked substantial liquidity. As a result, the firm now holds $117 million in cash, short-term assets, and Bitcoin, positioning it to roll out a multi-phase digital asset strategy.

“The sale of ACT Genomics was transformative,” said Danny Yeung, CEO of Prenetics. “It streamlined our business model and strengthened our capital base, enabling us to pursue a pioneering Bitcoin treasury approach.”

Yeung emphasized that this move is just the beginning. The company intends to dramatically grow its Bitcoin position, with plans to allocate a majority of its balance sheet to BTC.

“This isn’t just about buying Bitcoin — it’s about redefining treasury management in healthcare,” Yeung noted.

Fusing Healthcare Innovation with Blockchain Potential

Yeung highlighted the potential of intersecting healthcare with blockchain technologies, envisioning a future where genomics, personalized medicine, and digital assets converge.

“We are entering a new era,” he said. “Bitcoin is more than a treasury asset — it’s a gateway to technological synergy that could revolutionize human health, longevity, and wealth.”

Crypto Leadership Joins the Mission

To guide its long-term strategy, Prenetics has appointed key crypto figures:

• Andy Cheung, former COO of OKX, joins the board of directors. Cheung brings experience managing billions in crypto trading volume and aims to apply advanced strategies like derivatives and yield generation, moving beyond simple HODL approaches.

“This is not about passive storage,” Cheung said. “We’re looking at a dynamic treasury model powered by institutional-grade crypto finance.”

• Tracy Hoyos Lopez, who played a pivotal role in introducing Donald Trump to Bitcoin, joins as an advisor. Currently Chief of Staff for Strategic Initiatives at Kraken, Lopez brings deep legal, political, and regulatory experience, vital for corporate adoption.

“Danny isn’t just buying Bitcoin — he’s architecting the future of healthcare-meets-finance,” said Lopez.

• Also joining is Raphael Strauch, founder of TOKEN2049 and Alice Capital, who brings deep institutional investment experience and strong crypto community ties.

“Prenetics stands out with a bold, disciplined, and visionary strategy,” Strauch said. “This is the next wave of institutional Bitcoin adoption.”

Financial Strength to Back the Vision

Prenetics currently holds:

• $66 million in cash reserves

• A debt-free balance sheet

• A market cap of $97.9 million

• Q1 2025 revenue of $14.4 million, up 336.5% YoY

• Full-year guidance between $80M–$100M

The company’s stock is also reacting positively, up 8.5% in pre-market trading on Wednesday, after a 7% gain the previous day, according to TradingView data.

“We believe Bitcoin is the superior treasury asset for the digital age,” Yeung concluded. “This is a long-term transformation, not a short-term play.”